Peter Hjelmstrom

Director/Chief Executive Officer

Internal Displacement Monitoring Centre

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter Hjelmstrom is the Director and Chief Executive Officer at Uppsala Monitoring Centre in Sweden. His research primarily focuses on opioid use disorder, with recent articles exploring pharmacokinetic-pharmacodynamic analysis, patient-reported outcomes, and the factors influencing treatment approaches with buprenorphine and methadone. His work also addresses issues related to opioid-related deaths among various demographics in Sweden.

Articles (7)

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

Nicholas Lintzeris

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Hjelmstrom

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder

Oxycodone-related deaths in Sweden 2006-2018.

Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.

Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone

Methadone-related deaths among youth and young adults in Sweden 2006-2015.

Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.

Collaborators (1)

Nicholas Lintzeris

Make your next move.